Novosound is a deep-tech health-technology company developing next‑generation medical and lifestyle devices enabled by its proprietary thin-film ultrasound technology. The company addresses a major gap in today’s wearable sensor ecosystem by introducing scalable, cost-effective, and highly sensitive ultrasound sensors designed specifically for continuous, non-invasive health monitoring. Novosound’s current flagship development is a cuff-less, calibration‑free blood pressure monitoring device, leveraging the unique ability of thin-film ultrasound to deliver direct arterial measurements suitable for true wearable integration. With a global IP portfolio of more than 40 patents granted or pending, Novosound’s protected innovations span core materials, sensor manufacturing, system architectures, and end‑use applications. The company is positioned at the convergence of critical technologies, including MedTech, diagnostics, advanced sensor manufacturing, and digital health. By combining ultrasound expertise with scalable production processes, Novosound is establishing itself as a leader in the development of miniaturised, clinically meaningful wearable devices.